| 000 | 01741 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518090342.0 | ||
| 264 | 0 | _c20201111 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1664-3224 | ||
| 024 | 7 |
_a10.3389/fimmu.2019.03123 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMüller, Stephan | |
| 245 | 0 | 0 |
_aHigh Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia. _h[electronic resource] |
| 260 |
_bFrontiers in immunology _c2019 |
||
| 300 |
_a3123 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlpharetrovirus _xgenetics |
| 650 | 0 | 4 |
_aAntigens, CD19 _ximmunology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aGenetic Engineering |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xphysiology |
| 650 | 0 | 4 |
_aLentivirus _xgenetics |
| 650 | 0 | 4 |
_aPeptides _xmetabolism |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
| 650 | 0 | 4 | _aTransduction, Genetic |
| 700 | 1 | _aBexte, Tobias | |
| 700 | 1 | _aGebel, Veronika | |
| 700 | 1 | _aKalensee, Franziska | |
| 700 | 1 | _aStolzenberg, Eva | |
| 700 | 1 | _aHartmann, Jessica | |
| 700 | 1 | _aKoehl, Ulrike | |
| 700 | 1 | _aSchambach, Axel | |
| 700 | 1 | _aWels, Winfried S | |
| 700 | 1 | _aModlich, Ute | |
| 700 | 1 | _aUllrich, Evelyn | |
| 773 | 0 |
_tFrontiers in immunology _gvol. 10 _gp. 3123 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3389/fimmu.2019.03123 _zAvailable from publisher's website |
| 999 |
_c30691548 _d30691548 |
||